Study Type
Interventional - Drug
The objective of the POISE-2 study was to determine the impact of clonidine versus placebo and ASA versus placebo on the 30-day risk of all-cause mortality or nonfatal myocardial infarction in patients with, or at risk of, atherosclerotic disease who are undergoing noncardiac surgery.
Patients in the POISE-2 trial were randomly assigned to one of four groups:
Research personnel followed patients at 30 days post-randomization and one year post-randomization.
Primary endpoint:
Composite of all-cause mortality and nonfatal MI at 30 days after randomization.
Interventional - Drug
Randomized, double-blind, placebo control, factorial assignment
34
135
10010
2010-2014
PHRI
Back To Top